Gastrointestinal stromal tumors in children and young adults: A clinicopathologic and molecular genetic study of 22 Korean cases

APMIS

Volumn 121, Issue 10, 2013, Pages 938-944

  Kang, Guhyun ^a,g   Park, Young Soo ^b   Jung, Eun Sun ^c   Joo, Mee ^d   Kang, Mi Seon ^e   Ahn, Soomin ^a   Kang, Gu Hyum ^f   Kim, Kyoung Mee ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Inje University College of Medicine   (South Korea)

^e Inje University College of Medicine   (South Korea)

^f Chungnam National University College of Medicine   (South Korea)

^g Inje University   (South Korea)

Author keywords

Gastrointestinal stromal tumor; Pediatric; Succinate dehydrogenase subunit B

Indexed keywords

IMATINIB; NILOTINIB; PROTEIN S 100; SUCCINATE DEHYDROGENASE; SUNITINIB;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CHILD; CHILDHOOD CANCER; CLINICAL FEATURE; DISTANT METASTASIS; DUODENUM; ESOPHAGUS; EXON; FEMALE; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; JEJUNUM; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MITOSIS RATE; PERITONEUM METASTASIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; STOMACH; WILD TYPE;

GASTROINTESTINAL STROMAL TUMOR; PEDIATRIC; SUCCINATE DEHYDROGENASE SUBUNIT B;

ADOLESCENT; ADULT; AGE FACTORS; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CHILD; EXONS; FEMALE; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RETROSPECTIVE STUDIES; SUCCINATE DEHYDROGENASE;

EID: 84884719647     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.12085     Document Type: Article

References (22)

1. DeMatteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000;231:51-8.
2. Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 2005;29:52-68.
3. Miettinen M, Makhlouf H, Sobin LH, et al. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol 2006;30:477-89.
4. Stiller C. Childhood Cancer in Britain: Incidence, Survival, Mortality. Oxford; New York; Oxford University Press, 2007; viii, 270 p.
5. Pappo AS, Janeway K, Laquaglia M, et al. Special considerations in pediatric gastrointestinal tumors. J Surg Oncol 2011;104:928-32.
6. Agaram NP, Laquaglia MP, Ustun B, et al. Molecular characterization of pediatric gastrointestinal stromal tumors. Clin Cancer Res 2008;14:3204-15.
7. Miettinen M, Lasota J, Sobin LH. Gastrointestinal stromal tumors of the stomach in children and young adults: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature. Am J Surg Pathol 2005;29:1373-81.
8. Prakash S, Sarran L, Socci N, et al. Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature. J Pediatr Hematol Oncol 2005;27:179-87.
9. Pappo AS, Janeway KA. Pediatric gastrointestinal stromal tumors. Hematol Oncol Clin North Am 2009;23:15-34.
10. Rege TA, Wagner AJ, Corless CL, et al. "Pediatric-type" gastrointestinal stromal tumors in adults: distinctive histology predicts genotype and clinical behavior. Am J Surg Pathol 2011;35:495-504.
11. Gill AJ, Chou A, Vilain R, et al. Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types. Am J Surg Pathol 2010;34:636-44.
12. Gaal J, Stratakis CA, Carney JA, et al. SDHB immunohistochemistry: a useful tool in the diagnosis of Carney-Stratakis and Carney triad gastrointestinal stromal tumors. Mod Pathol 2011;24:147-51.
13. Miettinen M, Wang ZF, Sarlomo-Rikala M, et al. Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age. Am J Surg Pathol 2011;35:1712-21.
14. Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 2006;23:70-83.
15. Corless CL, McGreevey L, Haley A, et al. KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size. Am J Pathol 2002;160:1567-72.
16. Lasota J, Dansonka-Mieszkowska A, Sobin LH, et al. A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential. Lab Invest 2004;84:874-83.
17. Kim KM, Kang DW, Moon WS, et al. Gastrointestinal stromal tumors in Koreans: it's incidence and the clinical, pathologic and immunohistochemical findings. J Korean Med Sci 2005;20:977-84.
18. Carney JA. Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney Triad): natural history, adrenocortical component, and possible familial occurrence. Mayo Clin Proc 1999;74:543-52.
19. Carney JA. Carney triad: a syndrome featuring paraganglionic, adrenocortical, and possibly other endocrine tumors. J Clin Endocrinol Metab 2009;94:3656-62.
20. Benesch M, Leuschner I, Wardelmann E, et al. Gastrointestinal stromal tumours in children and young adults: a clinicopathologic series with long-term follow-up from the database of the Cooperative Weichteilsarkom Studiengruppe (CWS). Eur J Cancer 2011;47:1692-8.
21. Kaemmer DA, Otto J, Lassay L, et al. The Gist of literature on pediatric GIST: review of clinical presentation. J Pediatr Hematol Oncol 2009;31:108-12.
22. Gill AJ, Chou A, Vilain RE, et al. "Pediatric-type" gastrointestinal stromal tumors are SDHB negative ("type 2") GISTs. Am J Surg Pathol 2011; 35: 1245-7; author reply 7-8.